Form 4: Centene Director Kenneth Tanji Acquires Shares

Centene Corp Director Kenneth Tanji acquired 1,179 shares of common stock on March 31, 2026, under a pre-arranged trading plan.

Summary

• Kenneth Tanji, a Director of Centene Corp (CNC), is scheduled to acquire 1,179 shares of common stock.
• The transaction date for this acquisition is March 31, 2026, and the shares were acquired at a price of $0 per share, indicating a grant rather than a purchase.
• This acquisition is made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following this scheduled transaction, Tanji will beneficially own 7,917 shares of Centene common stock.
• Total ownership includes 3,579 shares of restricted stock units (RSUs) that are subject to vesting requirements.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director increasing their stake, even through a grant, aligns their interests with shareholders and suggests confidence in the company's long-term value.

Positives

• A Director, Kenneth Tanji, is increasing his beneficial ownership in Centene Corp by acquiring 1,179 shares, aligning his interests with shareholders.
• The acquisition is part of a pre-arranged Rule 10b5-1(c) plan, indicating a structured and pre-determined approach to insider transactions.

Future Outlook

This filing reports a scheduled insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider acquisitions, even if compensation-related and scheduled under a 10b5-1 plan, can signal management's continued confidence in the company's future prospects within the healthcare services industry. The use of a 10b5-1 plan suggests a pre-planned, rather than opportunistic, transaction.

Comparison to Industry Standards

• Insider transactions are a standard disclosure requirement across all industries, particularly for publicly traded companies.
• The acquisition of shares by a director at a $0 price is common for equity compensation plans, aligning with practices seen in other large healthcare providers like UnitedHealth Group (UNH) or Elevance Health (ELV), where executive and director compensation often includes restricted stock or similar equity awards.

Related Party Transactions

• The acquisition of 1,179 shares of common stock by Director Kenneth Tanji is a related party transaction.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders due to increased ownership, potentially signaling confidence in the company's future.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction related to compensation, specifically a scheduled grant of shares to a director under a pre-arranged plan. While it shows continued alignment of management interests with shareholders, it does not provide new fundamental information to warrant a change in investment recommendation. The transaction itself is not significant enough to alter the overall investment thesis for Centene Corp, thus a 'hold' recommendation is maintained.

Keywords

Centene Corp, CNC, Kenneth Tanji, Insider Trading, Form 4, Stock Acquisition, Director, Restricted Stock Units, 10b5-1 Plan